Young biotech venture firm raises $500 million for its second fund

What happens when two computer scientists and a former stem cell researcher become friends while working their way up the venture capital corporate ladder and decide to start their own firm?

Well, in Dimension’s case, they end up investing in some buzzy AI startups, counseling pharmaceutical companies, ribbing one another about expense reports, and — as of Monday — are able to raise $500 million for their second fund.

Dimension Capital launched in January 2023 after Zavain Dar, Adam Goulburn, and Nan Li decided to leave their posts at Lux Capital and Obvious Ventures and create their own investment firm, one focused on everything from life sciences software tools to therapeutics companies, manufacturing firms, and more. They raised $350 million for their first fund, which they’ve invested in 17 companies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$20

for 3 months, then $399/year

$20 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Log In